HEAT BIOLOGICS, INC. Business Finance Contracts & Agreements
68 Contracts & Agreements
- Assignment Agreements (4 contracts)
- Exchange Agreements (2)
- Funding Agreements (1)
- Investor Rights Agreements (1)
- Loan Agreements (10)
- Note Agreements (1)
- Registration Rights Agreements (1)
- Stock Agreements (15)
- Subscription Agreements (1)
- Underwriting Agreements (12)
- Warrant Agreements (20)
- Amendment No. 5 to the Rights Agreement dated as of March 11, 2023 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 13, 2023)
- Amendment No. 4 to the Rights Agreement dated as of March 8, 2021 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 11, 2022)
- Assignment and Assumption Agreement between Heat Biologics, Inc. and Pelican Therapeutics, Inc.(f/k/a Heat Biologics II, Inc.) dated June 26, 2009 (UM131-31, UM139) (Filed With SEC on March 11, 2022)
- Second Amendment to License Agreement between Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) and University of Miami dated August 11, 2009 (UMC-131, UMC-139)... (Filed With SEC on March 11, 2022)
- Form of New Non-Statutory Stock Option Agreement for awards subject to forfeiture (Filed With SEC on January 3, 2022)
- Form of Amended and Restated Restricted Stock Agreement (Filed With SEC on December 15, 2021)
- Amendment No. 3 to the Rights Agreement dated as of March 8, 2021 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 12, 2021)
- Form of Restricted Stock Agreement (Filed With SEC on January 6, 2021)
- Form of Exchange Agreement (Filed With SEC on March 3, 2020)
- Form of Warrant (Filed With SEC on January 21, 2020)
- Underwriting Agreement, dated January 16, 2020, between Heat Biologics, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on January 21, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on January 13, 2020)
- Form of Heat Biologics, Inc. Restricted Stock Agreement (Filed With SEC on January 3, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on October 25, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 25, 2019)
- Amendment No. 1 to the Rights Agreement dated as of March 8, 2019 to the Rights Agreement dated March 11, 2018 by and between Heat Biologics, Inc. and Continental Stock Transfer &... (Filed With SEC on March 12, 2019)
- Heat Biologics, Inc. Form of Restricted Stock Agreement (Filed With SEC on January 3, 2019)
- Form of Warrant (Filed With SEC on November 21, 2018)
- Underwriting Agreement, dated November 21, 2018, between Heat Biologics, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on November 21, 2018)
- Common Warrant (Filed With SEC on May 7, 2018)
- Underwriting Agreement by and between Heat Biologics, Inc. and A.G.P./Alliance Global Partners (A.G.P.), as representative of the underwriters, dated May 2, 2018 (Filed With SEC on May 7, 2018)
- Form of Common Warrant (Filed With SEC on May 2, 2018)
- Form of Warrant Agent Agreement between Heat Biologics, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 2, 2018)
- Form of Warrant Agent Agreement between Heat Biologics, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 2, 2018)
- Form of Warrant Agent Agreement between Heat Biologics, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 2, 2018)
- Form of Underwriting Agreement (Filed With SEC on May 2, 2018)
- Form of Underwriting Agreement (Filed With SEC on April 26, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on April 19, 2018)
- Common Stock Sales Agreement, dated January 18, 2018, by and between Heat Biologics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 19, 2018)
- Underwriting Agreement, dated November 17, 2017, between Heat Biologics, Inc. and Aegis Capital Corp (Filed With SEC on November 17, 2017)
- Form of Subscription Rights Certificate (Filed With SEC on September 15, 2017)
- Assignment and Assumption Agreement between Heat Biologics, Inc. and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated June 26, 2009 (UM03-31, UM05-39) (Filed With SEC on May 3, 2017)
- Funding Commitment issued by Heat Biologics, Inc. dated April 6, 2017 (Filed With SEC on April 7, 2017)
- First Amendment to Stock Purchase Agreement to Stock Purchase Agreement dated March 29, 2017 by and among Heat Biologics, Inc., Pelican Therapeutics, Inc. and Josiah Hornblower as... (Filed With SEC on March 31, 2017)
- Underwriting Agreement, dated March 23, 2017, between Heat Biologics, Inc. and Aegis Capital Corp (Filed With SEC on March 24, 2017)
- Stock Purchase Agreement, dated March 7, 2017, by and among Heat Biologics, Inc., Pelican Therapeutics, Inc., the stockholders of Pelican Therapeutics, Inc. party thereto (Filed With SEC on March 8, 2017)
- Form of Restricted Stock Unit Award Agreement (Filed With SEC on January 4, 2017)
- [FORM OF WARRANT] (Filed With SEC on March 18, 2016)
- FORM OF WARRANT (Filed With SEC on March 15, 2016)
- HEAT BIOLOGICS, INC. [] Shares of Common Stock and Warrants to Purchase Up to [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 15, 2016)
